Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

NCT00531635 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Interventions

DRUG: Mycophenolate Mofetil

Sponsor

King Faisal Specialist Hospital & Research Center